Prof. Vatish commented: "We are delighted to be taking part in this important study which is crucial to help us understand both the safety and immunogenicity of the Pfizer-BioNTech vaccine for pregnant women and their children. We know that approved COVID-19 vaccines are safe for pregnant women as per JCVI guidance, but this will add valuable information to our knowledge of how these vaccines work".’’
Success with the Pfizer Maternal C-19 Vaccine Trial
Maternal & Fetal Health
23 July 2021
Congratulations to Prof. Manu Vatish and the OSPREA-Gynae team on recruiting their first participant to the Pfizer maternal C-19 vaccine trial on 22nd July.
